EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease

Bernardo D'Onofrio iD, Giulia Virelli, Elisa Pedrollo, Marta Caprioli, Marta Riva, Daniela Renna, Antonio Tonutti, Nicoletta Luciano, Angela Ceribelli, Elisa Gremese, Maria De Santis iD, Carlo Selmi iD

Rheumatology Advances in Practice · 07.06.2024 · 8 (3)

DOI: 10.1093/rap/rkae105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 06.09.2024. Verfasst von Bernardo D'Onofrio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Parvovirus B19 most frequently causes epidemics of erythema infectiosum in children but also affects adults often leading to rheumatologic manifestations. While the serum profile allows the diagnosis, manifestations may mimic autoimmune conditions. The aim was to evaluate the proportion of patients with acute Parvovirus B19 infection fulfilling classification criteria for rheumatic diseases (RA and SLE).

Methods

We evaluated the clinical and serological features of 54 patients diagnosed with acute Parvovirus B19 infection seeking rheumatological attention between March and June 2024.

Results

The majority of patients were females (78%), with a mean (s.d.) age of 45 (13) years and 54% could not recall any known exposure. Fifty-one/54 (94%) had arthralgia, 27 (50%) arthritis (oligoarthritis in 67% of them), 24 (44%) fever, 19 (35%) skin rash and 7 (13%) purpura. Symptoms resolution generally occurred within 6 weeks. Complement levels were low in 14/33 (42%) tested patients, while the presence of serum ANA, anti-dsDNA, anti-phospholipids and rheumatoid factor was detected in 21/38 (55%), 10/26 (38%), 6/12 (50%) and 5/37 (13%) patients, respectively. Classification criteria for SLE were fulfilled in 93% of ANA-positive patients and RA criteria in 38% of patients with arthritis.

Conclusions

Parvovirus B19 infection manifestations may vary and nearly all patients with positive serum ANA fulfil the classification criteria for SLE. The risk of misclassification in patients with viral infection should not be overlooked.

Schlagwörter

Stichwörter der Autor:innen

RASLEclassification criteriasystemic autoimmune diseasesviral arthritis

Autor:innen und Institutionen

  • Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

ORCID-Profile: Bernardo D'Onofrio, Maria De Santis, Carlo Selmi

Zitieren

APA

D'Onofrio, B., Virelli, G., Pedrollo, E., Caprioli, M., Riva, M., Renna, D., Tonutti, A., Luciano, N., Ceribelli, A., Gremese, E., De Santis, M., & Selmi, C. (2024). High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease. Rheumatology Advances in Practice, 8(3). https://doi.org/10.1093/rap/rkae105

Vancouver

D'Onofrio B, Virelli G, Pedrollo E, Caprioli M, Riva M, Renna D, et al. High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease. Rheumatology Advances in Practice. 2024;8(3). doi:10.1093/rap/rkae105

BibTeX
@article{DOnofrio2024,
  author = {D'Onofrio, Bernardo and Virelli, Giulia and Pedrollo, Elisa and Caprioli, Marta and Riva, Marta and Renna, Daniela and Tonutti, Antonio and Luciano, Nicoletta and Ceribelli, Angela and Gremese, Elisa and De Santis, Maria and Selmi, Carlo},
  title = {High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease},
  journal = {Rheumatology Advances in Practice},
  year = {2024},
  volume = {8},
  number = {3},
  doi = {10.1093/rap/rkae105}
}
Kostenlos starten →